WHITBY GROUP PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: B82017 | WHITBY, YO21 1SD
Showing results 501-550 of 740
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Canagliflozin | 32 | 1,698 | £2.1K | -77.7% ▼ |
| Glucagon | 32 | 42 | £720 | +110.4% ▲ |
| Trospium chloride | 32 | 1,334 | £516 | -37.3% ▼ |
| Mefenamic acid | 32 | 1,752 | £327 | -29.2% ▼ |
| Cocois | 32 | 4,040 | £595 | +133.0% ▲ |
| 32 | 3,250 | £65 | +89.4% ▲ | |
| 32 | 70 | £474 | -10.5% ▼ | |
| 32 | 1,500 | £5.9K | +43.4% ▲ | |
| Levomepromazine hydrochloride | 31 | 236 | £450 | +34.6% ▲ |
| Brivaracetam | 30 | 1,549 | £3.4K | -11.8% ▼ |
| Midazolam hydrochloride | 30 | 120 | £2.5K | +108.2% ▲ |
| Levonorgestrel | 30 | 31 | £2.4K | -20.5% ▼ |
| Oral rehydration salts | 30 | 1,886 | £750 | +3.8% ▲ |
| 30 | 700 | £215 | -30.4% ▼ | |
| Sodium citrate (Rectal) | 29 | 220 | £145 | +110.2% ▲ |
| Empagliflozin/linagliptin | 29 | 812 | £1.5K | +123.7% ▲ |
| Propylthiouracil | 29 | 994 | £97 | +130.8% ▲ |
| Tamsulosin and dutasteride hydrochloride | 29 | 870 | £238 | -17.0% ▼ |
| Ascorbic acid | 29 | 980 | £1.1K | +41.2% ▲ |
| 29 | 332 | £912 | +84.8% ▲ | |
| 29 | 870 | £1.8K | +248.2% ▲ | |
| 29 | 2,000 | £101 | -46.6% ▼ | |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 28 | 1,204 | £555 | +71.2% ▲ |
| Colesevelam hydrochloride | 28 | 5,760 | £2.6K | -26.2% ▼ |
| Biphasic insulin lispro | 28 | 150 | £916 | -34.8% ▼ |
| Testosterone esters | 28 | 78 | £179 | +89.9% ▲ |
| Cabergoline | 28 | 264 | £460 | +80.6% ▲ |
| 28 | 124 | £248 | +15.6% ▲ | |
| Glycopyrronium bromide | 27 | 5,790 | £8.3K | +31.5% ▲ |
| Propantheline bromide | 27 | 2,688 | £2.3K | +108.0% ▲ |
| Enoxaparin | 27 | 638 | £3.9K | +31.7% ▲ |
| Desloratadine | 27 | 1,080 | £95 | -6.4% ▼ |
| Dexamfetamine sulfate | 27 | 1,148 | £1.3K | -24.9% ▼ |
| Water for injection | 27 | 380 | £111 | -20.2% ▼ |
| Liquid paraffin | 27 | 11.1K | £118 | +289.2% ▲ |
| Zinc oxide | 27 | 4,730 | £162 | +34.3% ▲ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 27 | 2,373 | £320 | +211.3% ▲ |
| 27 | 650 | £530 | +3.6% ▲ | |
| 27 | 870 | £562 | +75.3% ▲ | |
| Balsalazide sodium | 26 | 5,564 | £1.2K | +74.6% ▲ |
| Olmesartan medoxomil/amlodipine | 26 | 728 | £405 | +97.1% ▲ |
| Lurasidone | 26 | 728 | £2.0K | +4.2% ▲ |
| Azelastine hydrochloride | 26 | 572 | £258 | +132.0% ▲ |
| Pimecrolimus | 26 | 990 | £610 | +53.6% ▲ |
| Ivermectin | 26 | 1,185 | £690 | +22.3% ▲ |
| 26 | 417 | £803 | +90.6% ▲ | |
| 26 | 1,726 | £407 | +28.6% ▲ | |
| Nizatidine | 25 | 1,210 | £642 | -27.3% ▼ |
| Hydroxyzine hydrochloride | 25 | 1,211 | £39 | -53.1% ▼ |
| Zuclopenthixol hydrochloride | 25 | 2,500 | £136 | -20.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.